Trevena TRVN

Quarterly report 2024-Q3
added 11-07-2024

Trevena DIO Ratio 2011-2026 | TRVN

Annual DIO Ratio Trevena

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	197	450	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
450	197	323

Quarterly DIO Ratio Trevena

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	470	937	651	-	72.7	1.21 K	1.12 K	-	540	185	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.21 K	72.7	649

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Aptorum Group Limited APM	4.89	$ 0.88	-2.07 %	$ 6.47 M	China
	ACADIA Pharmaceuticals ACAD	295	$ 22.67	1.66 %	$ 3.76 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Aquestive Therapeutics AQST	120	$ 4.09	-0.24 %	$ 437 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 23.29	-0.56 %	$ 2.96 B	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.48	4.23 %	$ 394 M	Britain
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	CASI Pharmaceuticals CASI	47.4	-	-	$ 35.4 M	USA
	BioXcel Therapeutics BTAI	1.56 K	$ 1.06	-2.75 %	$ 12.9 M	USA